Skip to content

TuRong BuShen Fang decoction and the receptivity of endometrium in patients with PCOS effect of clinical research

TuRong BuShen Fang decoction and the receptivity of endometrium in patients with PCOS effect of clinical research

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOQ-17013588
Enrollment
Unknown
Registered
2017-11-29
Start date
2017-11-28
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovarian syndrome

Interventions

treatment group:Turongbushenfang

Sponsors

Gansu Provincial Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Meet the diagnosis standard of western medicine with association of European society of human reproduction (ESHRE) and the American society for reproductive medicine (the ASRM presents) in Rotterdam was launched in 2003, PCOS seminar standards: (1) loose hair ovulation or without ovulation; The clinical manifestations and (or) hyperandrogens of hyperandrogens; Ovary polycystic changes: the ovaries of one or both sides of the ovary were greater than 12, and the ovary volume increased > 10cm3. In the above three, two can be diagnosed as PCOS.

Exclusion criteria

Exclusion criteria: 1. The infertility of the man's factor; 2. The infertility of tubal factors; 3. To eliminate diseases: late onset congenital adrenal cortex hyperplasia, Cushing's syndrome, low gonadotropin gonad hormone sex amenorrhoea, ovarian or adrenal gland secretion of androgen tumor, thyroid dysfunction, hyperprolactinemia, etc.

Design outcomes

Primary

MeasureTime frame
sex hormone;

Countries

China

Contacts

Public ContactXu Caifeng

Gansu Provincial Hospital of TCM

xcfyx70@126.com+86 15002591710

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026